Anavex Life Sciences Corp. (AVXL)

4.40 +0.04 (+0.92%) USD  |  NASDAQ  |  Feb 25, 16:00
4.31 -0.09 (-2.05%) Pre-Market: 08:32
More

Anavex Life Sciences Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Nephros, Inc. Upgrade
Cabaletta Bio, Inc. --
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Ocugen, Inc. Upgrade